Keyphrases
Abiraterone
100%
Adverse Events
25%
Assessment Development
12%
Assessment System
12%
Bilateral Orchiectomy
12%
Castration
12%
Chemotherapy
12%
Cochrane
12%
Cochrane Library
12%
Confidence Interval
62%
Developmental Systems
12%
Embase
12%
Evaluation Assessment
12%
Evaluation System
12%
Free Time
25%
Grading of Recommendations
12%
Hazard Ratio
50%
Luteinizing Hormone
12%
Meta-analysis
100%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
100%
Nave
12%
New Standards
12%
Objective Response Rate
25%
Overall Survival
37%
Phase II Trial
12%
Placebo
37%
Prednisone
25%
Prior Chemotherapy
12%
Prostate Cancer
12%
PSA Progression
25%
PSA Response
25%
PubMed
12%
Radiographic Progression-free Survival
37%
Randomized Controlled Trial
37%
Risk of Bias
12%
Risk Ratio
37%
Science Libraries
12%
Stata
12%
Statistical Analysis
12%
Systematic Meta-analysis
100%
Time to Progression
12%
Web of Science
12%
Pharmacology, Toxicology and Pharmaceutical Science
Abiraterone
100%
Adverse Event
25%
Castration Resistant Prostate Cancer
100%
Chemotherapy
12%
Gonadorelin Derivative
12%
Overall Survival
37%
Patient History of Chemotherapy
12%
Placebo
37%
Prednisone
25%
Progression Free Survival
37%
Prostate Cancer
12%
Randomized Controlled Trial
37%
Agricultural and Biological Sciences
Abiraterone
100%
Confidence Interval
62%
Gonadotropin-Releasing Hormone Analogue
12%
Meta-Analysis
100%
Placebo
37%
Prednisone
25%
Spider Web
12%
Systematic Review
100%